Stephens Consulting, LLC Astrazeneca PLC Transaction History
Stephens Consulting, LLC
- $326 Billion
- Q1 2024
A detailed history of Stephens Consulting, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Stephens Consulting, LLC holds 755 shares of AZN stock, worth $57,984. This represents 0.02% of its overall portfolio holdings.
Number of Shares
755
Previous 882
14.4%
Holding current value
$57,984
Previous $59.4 Million
13.88%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.71 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.77 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.3 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.65 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $238B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...